Publications by authors named "Lana Schmidt"
Introduction: Apremilast, the first oral targeted treatment for moderate to severe psoriasis, is associated with diarrhea, nausea, and vomiting, which have contributed to treatment discontinuation. This study describes early apremilast discontinuation rates in patients with psoriasis, including a cohort with gastrointestinal (GI) comorbidities, and associated characteristics.
Methods: This retrospective cohort study used IBM (now Merative™) MarketScan commercial and Medicare claims data to identify adults with psoriasis who filled their first apremilast prescription between September 1, 2014 and March 31, 2020.
Article Synopsis
- COVID-19's impact on patients with kidney disease and their families was studied to understand changes in their lives and research involvement during the pandemic.
- Virtual interviews with 7 patient co-investigators and 8 stakeholders revealed emotional struggles, behavior changes, and altered healthcare delivery due to COVID-19.
- Despite the challenges, most participants reported no negative effects on their research engagement, and suggestions for future research included utilizing virtual activities and fostering transparency and trust.
Patients with Kidney Disease: Ready to Use Smartphones for Health Care Delivery?
Clin J Am Soc Nephrol
December 2020
We need more research projects that partner and engage with patients and family members as team members. Doing this requires that patients and family members set research priorities and fully participate in research teams. Models for this patient and family member engagement as research partners can help increase patient centered outcomes research.
View Article and Find Full Text PDF